Become a Member | Print Page | Contact Us | Report Abuse | Sign In
Clinical Trials

 

Thyroid cancer is the most common endocrine neoplasm and the incidence continues to rise worldwide. For many patients, standard therapy is effective for achieving long-term survival. Patients who develop aggressive or recurrent diseases represent a considerable therapeutic challenge, thus the search for novel treatment strategies for these difficult cases remains a key component of ITOG’s mission.

ITOG has partnered with pharmaceutical companies and other cancer groups in a concentrated effort to make headway in finding a path forward for these aggressive tumor types. Below, please find a list of ITOG’s active and upcoming clinical trials.  

 

 

Connect With Us

International Thyroid Oncology Group

5166 Commercial Drive

Yorkville, New York 13495

614-293-9779

 

Our mission
To catalyze a cure for the most challenging thyroid cancers through the collaborative efforts of our unique multidisciplinary team of leading physicians, scientists, and advocates to design, coordinate, and prioritize state-of-the-art clinical trials and correlative science.